If you're waking at 2 a.m. drenched in sweat, heart hammering, unable to get back to sleep, you're not imagining things. Vasomotor symptoms, the clinical term for hot flashes and night sweats, affect up to 80% of perimenopausal and menopausal women and rank as the single biggest driver of insomnia in this population. New data presented at the International Menopause Society's 2026 congress have put a sharper number on how much sleep these episodes actually steal, and what can be done about it. Here's what the science says.
What's Actually Happening in Your Body
The hypothalamus is your body's internal thermostat. It maintains core temperature within a narrow band by triggering sweating when you're too warm and shivering when you're too cold. Estrogen plays a quiet but critical role in calibrating that thermostat. As estrogen levels fall during perimenopause and menopause, the thermoregulatory set point becomes unstable. The hypothalamus starts interpreting normal body temperature as dangerously high and fires off a heat-release response, dilating blood vessels and flooding the skin with blood.
The result is a hot flash. During sleep, that same cascade produces night sweats, and the physiological arousal that accompanies the event, elevated heart rate, surging skin temperature, a spike in cortisol, pulls you out of deep slow-wave or REM sleep. Even if you don't fully wake, the sleep architecture is fragmented. Repeated fragmentation across a night accumulates into genuine sleep debt: less restoration, worse cognition, lower mood, and impaired metabolic function the next day.
Research using polysomnography shows that women with frequent vasomotor symptoms spend significantly less time in slow-wave sleep compared with symptom-free peers, even when total time in bed looks similar. That's the mechanism behind the exhaustion that feels disproportionate to how many hours you logged.
The New Data: Fezolinetant and Objective Sleep Improvement
Fezolinetant is a neurokinin 3 (NK3) receptor antagonist, a non-hormonal drug that targets the neurological pathway responsible for triggering hot flashes in the first place, rather than replacing estrogen. The OPTION-VMS trial data presented at IMS 2026 added an important dimension to the existing evidence base: objective sleep outcomes measured from week 4 through week 12.
The findings showed statistically significant reductions in nighttime vasomotor events and corresponding improvements in sleep quality scores by week 4. Those gains were sustained through week 12, which matters because many women and their doctors are understandably cautious about treatments that work short-term and fade. The effect size was meaningful enough to show up on objective measures, not just patient-reported questionnaires, which strengthens confidence in the signal.
Fezolinetant is currently approved by the FDA under the brand name Veozah for moderate-to-severe vasomotor symptoms in menopause. It's not appropriate for everyone, including people with certain liver conditions, and it requires a prescription and clinical evaluation. Cost and insurance coverage vary, but list prices in the US market are substantial, making insurance coverage and prior authorization a practical conversation to have with your provider. The takeaway from the IMS 2026 data isn't that everyone needs this drug. It's that pharmaceutical intervention targeting the neurological source of hot flashes can produce measurable sleep benefit, and that conversation is worth having with your physician if lifestyle changes haven't moved the needle enough.
Lifestyle Levers That Have Real Evidence Behind Them
Pharmaceutical options aren't the starting point for most people, and many women either prefer non-drug approaches or need to combine them with medication for full effect. The good news is that several lifestyle interventions have enough evidence to be worth taking seriously, rather than dismissed as wellness folklore.
Bedroom temperature. Keeping your sleeping environment below 18°C (65°F) is one of the more consistently supported environmental strategies. A cooler ambient temperature reduces the thermal load on the body before a vasomotor event begins, which can shorten duration and limit the degree of arousal. This is especially useful because you can implement it tonight. Moisture-wicking bedding, particularly sheets with high breathability, adds a second layer of protection by moving sweat away from the skin rather than trapping it against you. The difference in perceived discomfort between standard cotton and a well-designed moisture-wicking fabric during a night sweat is not subtle.
Alcohol timing. Alcohol is a vasodilator and disrupts sleep architecture independently of hot flashes. Consuming it within three hours of bedtime has been shown to increase the frequency and severity of nighttime vasomotor events. Moving your last drink earlier, or cutting it out during periods of severe disruption, is a practical lever that costs nothing and often produces noticeable results within a week.
Pre-sleep cooling. A lukewarm shower, rather than a hot one, in the 30 to 60 minutes before bed initiates the drop in core body temperature that naturally accompanies sleep onset. You're working with the body's own thermoregulatory rhythms rather than against them. Keeping a cooling towel or a small fan near the bed gives you an immediate response tool when a flash hits in the night.
Stress and the autonomic nervous system. Hot flash frequency correlates with heightened sympathetic nervous system activity. Slow, paced breathing techniques have been studied in this context. Research on coherent breathing and its effects on stress physiology suggests that regular practice can lower baseline sympathetic tone, which may reduce the frequency of vasomotor events over time. This is not a quick fix, but it's low-risk and can be layered on top of other strategies.
Exercise: Modest but Real Benefits
The relationship between exercise and vasomotor symptoms is more nuanced than fitness media typically presents. Earlier trials, including those from the SWAN study cohort, found that aerobic exercise alone did not dramatically reduce hot flash frequency compared with controls. But the picture improved when researchers looked at strength training specifically and at longer intervention periods.
More recent analysis suggests that regular resistance training is associated with modest but statistically significant reductions in VMS frequency and severity. The proposed mechanism involves improvements in autonomic regulation and a reduction in baseline sympathetic nervous system activity, similar to the pathway through which breathing practices help. The effect isn't dramatic enough to replace medical treatment in severe cases, but it's clinically meaningful in mild-to-moderate presentations.
The evidence on light lifting and its effects on mood and anxiety is also relevant here, since the sleep disruption from vasomotor symptoms often produces secondary anxiety and low mood that compound the problem. Resistance training addresses multiple nodes of that cycle simultaneously.
If you're building or rebuilding a training routine, you don't need an expensive gym setup. A well-considered home environment can be fully effective. Our guide on building a home gym without wasting money covers exactly how to do that. And if you want to make sure the exercise is actually moving the needle, tracking your strength progress systematically is how you confirm it is.
For women who have historically stayed away from weight training, the barrier is often more psychological and cultural than physical. The reasons behind that pattern and practical ways to address them are worth understanding before writing off resistance training as an option. The evidence now supports it clearly enough that it deserves a fair trial.
Putting It Together: A Practical Framework
Managing vasomotor-driven sleep disruption is rarely a single-intervention problem. The most effective approach stacks strategies across multiple categories simultaneously.
- Optimize your sleep environment: Set the thermostat below 18°C (65°F), switch to moisture-wicking bedding, and keep a cooling tool within reach at night.
- Adjust alcohol timing: Move your last drink to at least three hours before bed, or consider a temporary elimination period to assess the impact clearly.
- Add a pre-sleep cooling routine: A lukewarm shower or cooling breathwork in the 30 minutes before bed helps initiate the core temperature drop your body needs.
- Build consistent resistance training into your week: Two to three sessions per week appears to be the threshold where autonomic benefits accumulate. Even sessions shorter than 45 minutes count.
- Talk to your doctor about pharmaceutical options: If lifestyle interventions haven't produced enough improvement after four to six weeks of consistent effort, or if symptoms are severe from the start, non-hormonal options like fezolinetant now have trial data showing objective sleep benefit. Hormonal therapy also remains a valid option for many women, with an updated risk-benefit picture that has evolved considerably over the past decade.
The Bottom Line
Hot flashes aren't just uncomfortable. They're a physiological event that fragments your sleep architecture night after night, with downstream effects on mood, cognition, metabolism, and long-term health. The IMS 2026 OPTION-VMS data confirm that pharmaceutical intervention targeting the neurological trigger can produce real, sustained sleep improvement. That doesn't make medication the automatic answer, but it raises the bar for what "doing something about it" can look like.
The lifestyle strategies covered here aren't consolation prizes. Bedroom temperature, alcohol timing, exercise, and breathing practices each have genuine evidence. Used together, they can meaningfully reduce the burden of symptoms, and they work on the same nights you're waiting for other interventions to take effect.
Your sleep quality during this phase of life is not something you have to simply endure. Start with what you can control tonight, and bring the full picture to your next clinical appointment.